Literature DB >> 25847964

AMA1-deficient Toxoplasma gondii parasites transiently colonize mice and trigger an innate immune response that leads to long-lasting protective immunity.

Vanessa Lagal1, Márcia Dinis1, Dominique Cannella2, Daniel Bargieri3, Virginie Gonzalez1, Nicole Andenmatten4, Markus Meissner4, Isabelle Tardieux5.   

Abstract

The apical membrane antigen 1 (AMA1) protein was believed to be essential for the perpetuation of two Apicomplexa parasite genera, Plasmodium and Toxoplasma, until we genetically engineered viable parasites lacking AMA1. The reduction in invasiveness of the Toxoplasma gondii RH-AMA1 knockout (RH-AMA1(KO)) tachyzoite population, in vitro, raised key questions about the outcome associated with these tachyzoites once inoculated in the peritoneal cavity of mice. In this study, we used AMNIS technology to simultaneously quantify and image the parasitic process driven by AMA1(KO) tachyzoites. We report their ability to colonize and multiply in mesothelial cells and in both resident and recruited leukocytes. While the RH-AMA1(KO) population amplification is rapidly lethal in immunocompromised mice, it is controlled in immunocompetent hosts, where immune cells in combination sense parasites and secrete proinflammatory cytokines. This innate response further leads to a long-lasting status immunoprotective against a secondary challenge by high inocula of the homologous type I or a distinct type II T. gondii genotypes. While AMA1 is definitively not an essential protein for tachyzoite entry and multiplication in host cells, it clearly assists the expansion of parasite population in vivo.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25847964      PMCID: PMC4432741          DOI: 10.1128/IAI.02606-14

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  53 in total

Review 1.  Veterinary vaccines against Toxoplasma gondii.

Authors:  Elisabeth A Innes; Paul M Bartley; Stephen Maley; Frank Katzer; David Buxton
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-03       Impact factor: 2.743

2.  Host cell entry by apicomplexa parasites requires actin polymerization in the host cell.

Authors:  Virginie Gonzalez; Audrey Combe; Violaine David; Nicholas A Malmquist; Violaine Delorme; Carole Leroy; Samantha Blazquez; Robert Ménard; Isabelle Tardieux
Journal:  Cell Host Microbe       Date:  2009-03-19       Impact factor: 21.023

3.  A novel population of Gr-1+-activated macrophages induced during acute toxoplasmosis.

Authors:  Dana G Mordue; L David Sibley
Journal:  J Leukoc Biol       Date:  2003-09-12       Impact factor: 4.962

Review 4.  The IRG protein-based resistance mechanism in mice and its relation to virulence in Toxoplasma gondii.

Authors:  Jonathan C Howard; Julia P Hunn; Tobias Steinfeldt
Journal:  Curr Opin Microbiol       Date:  2011-07-23       Impact factor: 7.934

5.  Vaccines against Toxoplasma gondii: status, challenges and future directions.

Authors:  Qi Liu; Lachhman Das Singla; Huaiyu Zhou
Journal:  Hum Vaccin Immunother       Date:  2012-08-21       Impact factor: 3.452

6.  Type II Toxoplasma gondii KU80 knockout strains enable functional analysis of genes required for cyst development and latent infection.

Authors:  Barbara A Fox; Alejandra Falla; Leah M Rommereim; Tadakimi Tomita; Jason P Gigley; Corinne Mercier; Marie-France Cesbron-Delauw; Louis M Weiss; David J Bzik
Journal:  Eukaryot Cell       Date:  2011-04-29

7.  miR-146a and miR-155 delineate a MicroRNA fingerprint associated with Toxoplasma persistence in the host brain.

Authors:  Dominique Cannella; Marie-Pierre Brenier-Pinchart; Laurence Braun; Jason M van Rooyen; Alexandre Bougdour; Olivier Bastien; Michael S Behnke; Rose-Laurence Curt; Aurélie Curt; Jeroen P J Saeij; L David Sibley; Hervé Pelloux; Mohamed-Ali Hakimi
Journal:  Cell Rep       Date:  2014-02-27       Impact factor: 9.423

8.  Avirulent Toxoplasma gondii generates therapeutic antitumor immunity by reversing immunosuppression in the ovarian cancer microenvironment.

Authors:  Jason R Baird; Barbara A Fox; Kiah L Sanders; Patrick H Lizotte; Juan R Cubillos-Ruiz; Uciane K Scarlett; Melanie R Rutkowski; Jose R Conejo-Garcia; Steven Fiering; David J Bzik
Journal:  Cancer Res       Date:  2013-05-23       Impact factor: 12.701

Review 9.  Structure and function of mesothelial cells.

Authors:  S E Mutsaers; S Wilkosz
Journal:  Cancer Treat Res       Date:  2007

10.  Comparison of two DNA targets for the diagnosis of Toxoplasmosis by real-time PCR using fluorescence resonance energy transfer hybridization probes.

Authors:  Udo Reischl; Stéphane Bretagne; Dominique Krüger; Pauline Ernault; Jean-Marc Costa
Journal:  BMC Infect Dis       Date:  2003-05-02       Impact factor: 3.090

View more
  11 in total

Review 1.  Imaging flow cytometry analysis of intracellular pathogens.

Authors:  Viraga Haridas; Shahin Ranjbar; Ivan A Vorobjev; Anne E Goldfeld; Natasha S Barteneva
Journal:  Methods       Date:  2016-09-15       Impact factor: 3.608

Review 2.  Advances in Toxoplasma gondii Vaccines: Current Strategies and Challenges for Vaccine Development.

Authors:  Ki-Back Chu; Fu-Shi Quan
Journal:  Vaccines (Basel)       Date:  2021-04-21

3.  Metabolomic Profiling of Mice Serum during Toxoplasmosis Progression Using Liquid Chromatography-Mass Spectrometry.

Authors:  Chun-Xue Zhou; Dong-Hui Zhou; Hany M Elsheikha; Yu Zhao; Xun Suo; Xing-Quan Zhu
Journal:  Sci Rep       Date:  2016-01-20       Impact factor: 4.379

4.  Eimeria tenella Eimeria-specific protein that interacts with apical membrane antigen 1 (EtAMA1) is involved in host cell invasion.

Authors:  Cong Li; Qiping Zhao; Shunhai Zhu; Qingjie Wang; Haixia Wang; Shuilan Yu; Yu Yu; Shashan Liang; Huanzhi Zhao; Bing Huang; Hui Dong; Hongyu Han
Journal:  Parasit Vectors       Date:  2020-07-25       Impact factor: 3.876

5.  Kinetics of Mimivirus Infection Stages Quantified Using Image Flow Cytometry.

Authors:  Liran Ben Yaakov; Yael Mutsafi; Ziv Porat; Tali Dadosh; Abraham Minsky
Journal:  Cytometry A       Date:  2019-04-24       Impact factor: 4.355

6.  An endocytic-secretory cycle participates in Toxoplasma gondii in motility.

Authors:  Simon Gras; Elena Jimenez-Ruiz; Christen M Klinger; Katja Schneider; Andreas Klingl; Leandro Lemgruber; Markus Meissner
Journal:  PLoS Biol       Date:  2019-06-24       Impact factor: 8.029

7.  Topological integration of RPPA proteomic data with multi-omics data for survival prediction in breast cancer via pathway activity inference.

Authors:  Tae Rim Kim; Hyun-Hwan Jeong; Kyung-Ah Sohn
Journal:  BMC Med Genomics       Date:  2019-07-11       Impact factor: 3.063

Review 8.  Key Limitations and New Insights Into the Toxoplasma gondii Parasite Stage Switching for Future Vaccine Development in Human, Livestock, and Cats.

Authors:  Marie-Noëlle Mévélec; Zineb Lakhrif; Isabelle Dimier-Poisson
Journal:  Front Cell Infect Microbiol       Date:  2020-11-25       Impact factor: 5.293

9.  Not a Simple Tether: Binding of Toxoplasma gondii AMA1 to RON2 during Invasion Protects AMA1 from Rhomboid-Mediated Cleavage and Leads to Dephosphorylation of Its Cytosolic Tail.

Authors:  Shruthi Krishnamurthy; Bin Deng; Roxana Del Rio; Kerry R Buchholz; Moritz Treeck; Siniša Urban; John Boothroyd; Ying-Wai Lam; Gary E Ward
Journal:  mBio       Date:  2016-09-13       Impact factor: 7.867

10.  Toxoplasma gondii α-amylase deletion mutant is a promising vaccine against acute and chronic toxoplasmosis.

Authors:  Jing Yang; Chenghang Yang; Jiahui Qian; Facai Li; Junlong Zhao; Rui Fang
Journal:  Microb Biotechnol       Date:  2020-09-22       Impact factor: 5.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.